1859, Inc.
Biotechnology company · San Diego, California, United States
1859, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2021.
1859 at a glance
What does 1859 do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $40 million sold (2021).
Frequently asked questions about 1859
Where is 1859 headquartered?
1859, Inc. is headquartered in San Diego, California, United States.
What does 1859 do?
1859, Inc. is a biotechnology company.
When was 1859 founded?
The earliest incorporation on record for 1859, Inc. is in 2019, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences